Contact Ras Therapeutics
Therapeutics
Ras Therapeutics HomepageRas TherapeuticsTechnology - Ras TherapeuticsRas TherapeuticsScientific Advisory Board - Ras TherapeuticsRas TherapeuticsManagement - Ras TherapeuticsRas TherapeuticsContact Ras Therapeutics
Therapeutics, Onconlogy
Therapeutics

Selected Readings

  1. Xing HR, Cordon-Cardo C, Deng X, Ton W, Campodonico L, Fuks Z, Kolesnick R. Phamacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer. Nature Medicine. 2003 Oct 9(10):1267-1268.
  2. Konfield K, Horn D, Horvitz H. The KSR-1 gene encodes a novel protein kinase involved in ras-mediated signaling in C. elegans. Cell. 1995 Dec 83:903-913.
  3. Xing HR, Kolesnick R. Kinase suppressor of ras signals through Thr269 of c-Raf-1. J Biological Chemistry. 2001 Mar 276(13):9733-9741.
  4. Xing HR, Campondonico L, Kolesnick R. The kinase activity of kinase suppressor of Ras1 (KSR1) is independent of bound MEK. J Biological Chemistry. 2004 Jun 279(25):26210-26214.
  5. Xing HR, Lozano J, Kolesnick R. Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of ras. J Biological Chemistry. 2000 Jun 275(23):17276-17280.
  6. Therrien M, Chang H, Solomon N, Karim F, Wassarman D, Rubin G. KSR, a novel protein kinase required for ras signal transduction. Cell. 1995 Dec 83:879-888.
  7. Sundaram M, Han M. The C-elegans ksr-1 gene encodes a novel raf-related kinase involved in ras-mediated signal transduction. Cell. 1995 Dec 83(888-901).
Therapeutics, Cancer Treatment
Targeted Cancer Therapies
oncology
Copyright © 2007 Ras Therapeutics, Inc. All rights reserved.
Contact Ras Therapeutics Ras Therapeutics Homepage